Morningstar Investment Services’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $707K | Buy |
|
|||||
|
2024
Q2 | $644K | Sell |
|
|||||
|
2024
Q1 | $580K | Sell |
|
|||||
|
2023
Q4 | $833K | Buy |
|
|||||
|
2023
Q3 | $401K | Buy |
|
|||||
|
2023
Q2 | $281K | Buy |
|
|||||
|
2023
Q1 | $308K | Buy |
|
|||||
|
2022
Q4 | $311K | Sell |
|
|||||
|
2022
Q3 | $292K | Buy |
|
|||||
|
2022
Q2 | $256K | Buy |
|
|||||
|
2022
Q1 | $245K | Buy |
|
|||||
|
2021
Q4 | $202K | Buy |
|
|||||
|
2021
Q3 | $233K | Buy |
|
|||||
|
2021
Q2 | $195K | Buy |
|
|||||
|
2021
Q1 | $176K | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $198K | Sell |
|
|||||
|
2020
Q2 | $281K | Sell |
|
|||||
|
2020
Q1 | $208K | Sell |
|
|||||
|
2019
Q4 | $244K | Sell |
|
|||||
|
2019
Q3 | $202K | Sell |
|
|||||
|
2019
Q2 | $298K | Buy |
|
|||||
|
2019
Q1 | $363K | Sell |
|
|||||
|
2018
Q4 | $403K | Sell |
|
|||||
|
2018
Q3 | $577K | Sell |
|
|||||
|
2018
Q2 | $687K | Buy |
|
|||||
|
2018
Q1 | $412K | Sell |
|
|||||
|
2017
Q4 | $463K | Buy |
|
|||||
|
2017
Q3 | $387K | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $884K | Sell |
|
|||||
|
2014
Q3 | $1.31M | Sell |
|
|||||
|
2014
Q2 | $5.17M | Sell |
|
|||||
|
2014
Q1 | $9.52M | Buy |
|
|||||
|
2013
Q4 | $6.66M | Buy |
|
|||||
|
2013
Q3 | $5.08M | Buy |
|
|||||
|
2013
Q2 | $3.03M | Buy |
|